GLP-3R / CAG 12.5MG / 2.5MG

Description

GLP-3R/Cag 12.5mg / 2.5mg

GLP-3R/Cag 12.5mg/2.5mg is a dual-pathway peptide formulation combining GLP-3R (12.5mg) and Cagri (2.5mg).

Key Features

Dual Receptor Pathway Interaction
Integrates GLP-1/GIP/Glucagon receptor activity associated with NP-3RT. Alongside the amylin-analog properties of Cagri for comprehensive metabolic signaling research.

High Purity, GMP-Compliant Manufacturing
Manufactured in U.S.-based facilities under strict GMP standards to ensure batch consistency, sterility, and research-grade quality.

Here is a strong, compliance-focused disclaimer tailored specifically for your GLP-3R/Cag 12.5mg / 2.5mg product content:

Disclaimer

We supply GLP-3R/Cag 12.5mg/2.5mg strictly for laboratory research purposes only. You must not use this product for human or veterinary use, consumption, or administration of any kind. Regulatory authorities, including the U.S. FDA, have not approved it. Food and Drug Administration (FDA) or any other regulatory authority for diagnostic, therapeutic, or clinical applications.

All information provided is for scientific and educational reference only and does not constitute medical advice. Qualified professionals must handle this product in controlled laboratory environments in full compliance with all applicable local, state, and federal laws and regulations.